165 related articles for article (PubMed ID: 17873896)
21. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinase in uterine endometrial carcinoma and a correlation between expression of matrix metalloproteinase-7 and prognosis.
Misugi F; Sumi T; Okamoto E; Nobeyama H; Hattori K; Yoshida H; Matsumoto Y; Yasui T; Honda K; Ishiko O
Int J Mol Med; 2005 Oct; 16(4):541-6. PubMed ID: 16142384
[TBL] [Abstract][Full Text] [Related]
22. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.
Gress TM; Müller-Pillasch F; Lerch MM; Friess H; Büchler M; Adler G
Int J Cancer; 1995 Aug; 62(4):407-13. PubMed ID: 7635566
[TBL] [Abstract][Full Text] [Related]
23. Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma.
Qiao ZK; Li YL; Lu HT; Wang KL; Xu WH
World J Surg Oncol; 2013 Jan; 11():1. PubMed ID: 23281640
[TBL] [Abstract][Full Text] [Related]
24. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta1.
Ma C; Tarnuzzer RW; Chegini N
Wound Repair Regen; 1999; 7(6):477-85. PubMed ID: 10633007
[TBL] [Abstract][Full Text] [Related]
25. Role of matrix metalloproteinases and their inhibitors in the development of cervical metastases in papillary thyroid cancer.
Bumber B; Marjanovic Kavanagh M; Jakovcevic A; Sincic N; Prstacic R; Prgomet D
Clin Otolaryngol; 2020 Jan; 45(1):55-62. PubMed ID: 31646745
[TBL] [Abstract][Full Text] [Related]
26. Expression of matrix metalloproteinase-26 and tissue inhibitor of metalloproteinase-4 in human normal cytotrophoblast cells and a choriocarcinoma cell line, JEG-3.
Zhang J; Cao YJ; Zhao YG; Sang QX; Duan EK
Mol Hum Reprod; 2002 Jul; 8(7):659-66. PubMed ID: 12087081
[TBL] [Abstract][Full Text] [Related]
27. [Role of matrix metalloproteinases-9, 2 and their inhibitor-TIMP-1, 2 in invasive pituitary adenomas biological behavior].
He DS; Chen MZ; Wang HJ; Ke CL; Yan C; Zheng H; Hong YS
Ai Zheng; 2002 Oct; 21(10):1124-8. PubMed ID: 12508658
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical Expression Profiles of Cell Adhesion Molecules, Matrix Metalloproteinases and their Tissue Inhibitors in Central and Peripheral Neoplastic Foci of Feline Mammary Carcinoma.
Pisamai S; Rungsipipat A; Kunnasut N; Suriyaphol G
J Comp Pathol; 2017; 157(2-3):150-162. PubMed ID: 28942298
[TBL] [Abstract][Full Text] [Related]
29. Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
Baldini E; Toller M; Graziano FM; Russo FP; Pepe M; Biordi L; Marchioni E; Curcio F; Ulisse S; Ambesi-Impiombato FS; D'Armiento M
Thyroid; 2004 Nov; 14(11):881-8. PubMed ID: 15671765
[TBL] [Abstract][Full Text] [Related]
30. Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential.
Kousidou OC; Roussidis AE; Theocharis AD; Karamanos NK
Anticancer Res; 2004; 24(6):4025-30. PubMed ID: 15739263
[TBL] [Abstract][Full Text] [Related]
31. Latanoprost stimulates secretion of matrix metalloproteinases in tenon fibroblasts both in vitro and in vivo.
Mietz H; Esser JM; Welsandt G; Kociok N; Hueber A; Joussen A; Esser P; Krieglstein GK
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5182-8. PubMed ID: 14638715
[TBL] [Abstract][Full Text] [Related]
32. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
33. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue.
Lichtinghagen R; Musholt PB; Lein M; Römer A; Rudolph B; Kristiansen G; Hauptmann S; Schnorr D; Loening SA; Jung K
Eur Urol; 2002 Oct; 42(4):398-406. PubMed ID: 12361907
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in gastric cancer.
Shim KN; Jung SA; Joo YH; Yoo K
J Gastroenterol; 2007 Feb; 42(2):120-8. PubMed ID: 17351800
[TBL] [Abstract][Full Text] [Related]
35. Response of matrix metalloproteinases and tissue inhibitors of metalloproteinases messenger ribonucleic acids to ovarian steroids in human endometrial explants mimics their gene- and phase-specific differential control in vivo.
Vassilev V; Pretto CM; Cornet PB; Delvaux D; Eeckhout Y; Courtoy PJ; Marbaix E; Henriet P
J Clin Endocrinol Metab; 2005 Oct; 90(10):5848-57. PubMed ID: 16046583
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas.
Nakano A; Tani E; Miyazaki K; Yamamoto Y; Furuyama J
J Neurosurg; 1995 Aug; 83(2):298-307. PubMed ID: 7616276
[TBL] [Abstract][Full Text] [Related]
37. Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue.
Palosaari H; Pennington CJ; Larmas M; Edwards DR; Tjäderhane L; Salo T
Eur J Oral Sci; 2003 Apr; 111(2):117-27. PubMed ID: 12648263
[TBL] [Abstract][Full Text] [Related]
38. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in non-small-cell lung cancer.
Suzuki M; Iizasa T; Fujisawa T; Baba M; Yamaguchi Y; Kimura H; Suzuki H
Invasion Metastasis; 1998-1999; 18(3):134-41. PubMed ID: 10474026
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
40. Expression of matrix metalloproteinases in cyclosporin-treated gingival fibroblasts is regulated by transforming growth factor (TGF)-beta1 autocrine stimulation.
Cotrim P; de Andrade CR; Martelli-Junior H; Graner E; Sauk JJ; Coletta RD
J Periodontol; 2002 Nov; 73(11):1313-22. PubMed ID: 12479636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
